Literature DB >> 12970283

Establishment of reference intervals for markers of fetal thyroid status in amniotic fluid.

Pratima K Singh1, Curtis A Parvin, Ann M Gronowski.   

Abstract

Fetal goiter can arise as a result of fetal hyper or hypothyroidism. Although this condition is rare, it can be life threatening. Detection of fetal goiter in utero is possible with the aid of ultrasound, but proper prenatal treatment depends on knowledge of hormonal status. Amniotic fluid (AF) sampling is less technically demanding and poses fewer risks to the fetus than cordocentesis for fetal serum sampling, but well-established reference ranges for AF thyroid studies are not available in the literature. We have established reference intervals for AF (TSH), total T(4) (tT(4)), and free T(4) using stored AF samples. The reference intervals were: TSH (n = 127), less than 0.1-0.5 mU/liter, with a median of 0.1 mU/liter; tT(4) (n = 129), 2.3-3.9 microg/dl (30-50 nmol/liter), with a median of 3.3 microg/dl (4 nmol/liter); and free T(4) (n = 119) less than 0.4-0.7 ng/dl (5-9 pmol/liter), with a median of 0.4 ng/dl (5 pmol/liter). These intervals represent the largest study done to date on third trimester AF using automated immunoassays. A literature search of fetal goiter revealed a number of cases of hypothyroidism. Seven cases reported AF TSH concentrations (range, 1.1-28.9 mU/liter) and four reported AF tT(4) concentrations [range, 0.98-1.25 micro g/ml (13-16 nmol/liter)], all of which fell outside our reference intervals. These data support the use of AF to diagnose fetal hypothyroidism, reducing the need to resort to a riskier procedure such as cordocentesis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12970283     DOI: 10.1210/jc.2003-030522

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

Review 1.  The role of the placenta in thyroid hormone delivery to the fetus.

Authors:  Shiao Y Chan; Elisavet Vasilopoulou; Mark D Kilby
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-01

2.  MATERNAL GRAVES DISEASE AND ABNORMAL CYP2D6 GENOTYPE WITH FETAL HYPERTHYROIDISM.

Authors:  Christopher Spoke; Christopher Martin
Journal:  AACE Clin Case Rep       Date:  2020-04-03

3.  Neonatal hypothyroidism despite maternal tri-iodothyronine toxicosis: a management problem?

Authors:  Vasant V Shenoy; Janelle Nisbet; Scott G Petersen; H David Mcintyre
Journal:  Obstet Med       Date:  2012-03-09

Review 4.  Current knowledge about the in utero and peripartum management of fetal goiter associated with maternal Graves' disease.

Authors:  Shigeo Iijima
Journal:  Eur J Obstet Gynecol Reprod Biol X       Date:  2019-05-02

Review 5.  Hyperthyroidism in childhood: causes, when and how to treat.

Authors:  Juliane Léger; Jean Claude Carel
Journal:  J Clin Res Pediatr Endocrinol       Date:  2013
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.